DNA repair contributes to the drug-resistant phenotype of primary acute myeloid leukaemia cells with FLT3 internal tandem duplications and is reversed by the FLT3 inhibitor PKC412
Open Access
- 26 October 2006
- journal article
- research article
- Published by Springer Science and Business Media LLC in Leukemia
- Vol. 20 (12), 2130-2136
- https://doi.org/10.1038/sj.leu.2404439
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- FLT3-ITD-TKD dual mutants associated with AML confer resistance to FLT3 PTK inhibitors and cytotoxic agents by overexpression of Bcl-x(L)Blood, 2005
- Patients with acute myeloid leukemia and an activating mutation in FLT3 respond to a small-molecule FLT3 tyrosine kinase inhibitor, PKC412Published by American Society of Hematology ,2005
- Rad51 overexpression promotes alternative double-strand break repair pathways and genome instabilityOncogene, 2004
- BCR/ABL Regulates Mammalian RecA Homologs, Resulting in Drug ResistanceMolecular Cell, 2001
- Ribozyme minigene-mediated RAD51 down-regulation increases radiosensitivity of human prostate cancer cellsNucleic Acids Research, 2001
- Characterization of mammalian RAD51 double strand break repair using non-lethal dominant-negative formsThe EMBO Journal, 2000
- DNA repair and recombination factor Rad51 is over-expressed in human pancreatic adenocarcinomaOncogene, 2000
- Tandem-duplicated Flt3 constitutively activates STAT5 and MAP kinase and introduces autonomous cell growth in IL-3-dependent cell linesOncogene, 2000
- In Vitroandin VivoPotentiation of Radiosensitivity of Malignant Gliomas by Antisense Inhibition of the RAD51 GeneBiochemical and Biophysical Research Communications, 1998
- Elevated Recombination in Immortal Human Cells Is Mediated by HsRAD51 RecombinaseMolecular and Cellular Biology, 1997